| __timestamp | Exelixis, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2043000 | 79838000 |
| Thursday, January 1, 2015 | 3895000 | 121816000 |
| Friday, January 1, 2016 | 6552000 | 117633000 |
| Sunday, January 1, 2017 | 15066000 | 4577000 |
| Monday, January 1, 2018 | 26348000 | 12670000 |
| Tuesday, January 1, 2019 | 33097000 | 12135000 |
| Wednesday, January 1, 2020 | 36272000 | 18942000 |
| Friday, January 1, 2021 | 52873000 | 32328000 |
| Saturday, January 1, 2022 | 57909000 | 44678000 |
| Sunday, January 1, 2023 | 72547000 | 65486000 |
| Monday, January 1, 2024 | 0 |
In pursuit of knowledge
In the ever-evolving biotech industry, understanding cost structures is crucial for investors and stakeholders. Exelixis, Inc. and PTC Therapeutics, Inc. have shown distinct trajectories in their cost of revenue from 2014 to 2023. Exelixis, Inc. has experienced a remarkable growth, with its cost of revenue increasing by over 3,400% from 2014 to 2023. This surge reflects the company's expanding operations and market presence. In contrast, PTC Therapeutics, Inc. saw a more volatile pattern, with a significant drop in 2017, followed by a steady recovery, culminating in a 18% increase from 2022 to 2023. These trends highlight the dynamic nature of the biotech sector, where strategic investments and market conditions can significantly impact financial outcomes. Investors should consider these insights when evaluating potential opportunities in the biotech landscape.
Cost Insights: Breaking Down Eli Lilly and Company and PTC Therapeutics, Inc.'s Expenses
Novartis AG vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Vertex Pharmaceuticals Incorporated and PTC Therapeutics, Inc.
Cost of Revenue: Key Insights for Neurocrine Biosciences, Inc. and Exelixis, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Exelixis, Inc.
Cost Insights: Breaking Down Catalent, Inc. and PTC Therapeutics, Inc.'s Expenses
R&D Insights: How Exelixis, Inc. and PTC Therapeutics, Inc. Allocate Funds
Cost of Revenue Trends: Exelixis, Inc. vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Exelixis, Inc. vs Galapagos NV
Cytokinetics, Incorporated vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: PTC Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses